Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-α

Internal Medicine

Volumn 48, Issue 5, 2009, Pages 373-375

  Hirotani, Makoto ^a   Nakano, Hitoshi ^b   Ura, Shigehisa ^b   Yoshida, Kazuto ^b   Niino, Masaaki ^a   Yabe, Ichiro ^a   Sasaki, Hidenao ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b ASAHIKAWA RED CROSS HOSPITAL   (Japan)

Author keywords

Chronic inflammatory demyelinating polyneuropathy; Hepatitis C virus; Interferon

Indexed keywords

ALPHA INTERFERON; IMMUNOGLOBULIN; PROTEIN; RIBAVIRIN; VIRUS RNA; ANTIVIRUS AGENT;

ADULT; ANALGESIA (SENSORY DYSFUNCTION); ARTICLE; ATAXIA; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY; DRUG RESPONSE; DRUG WITHDRAWAL; DYSESTHESIA; HEPATITIS C; HUMAN; LIVER DYSFUNCTION; MALE; MOTOR NERVE CONDUCTION; MUSCLE WEAKNESS; NERVE CONDUCTION; NEUROLOGIC EXAMINATION; PERONEUS NERVE; PROTEIN BLOOD LEVEL; SENSORY EVALUATION; TEMPERATURE SENSITIVITY; TENDON REFLEX; TIBIAL NERVE; VIBRATION SENSE; WALKING DIFFICULTY; CHEMICALLY INDUCED DISORDER; DEMYELINATING DISEASE; POLYNEUROPATHY;

ADULT; ANTIVIRAL AGENTS; DEMYELINATING DISEASES; HEPATITIS C, CHRONIC; HUMANS; IMMUNOGLOBULINS; INTERFERON-ALPHA; MALE; POLYNEUROPATHIES;

EID: 66149190957     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.48.1616     Document Type: Article

References (18)

1. Burman P, Karlsson A, Oberg K, Alm G, Orava M, Vihko R. Autoimmune thyroid disease in interferon-treated patients. Lancet 8446: 100-101, 1985.
2. Konoshi T. A case of myasthenia gravis which developed myaesthenic crisis after alpha-interferon therapy for chronic hepatitis C. Clin Neurol 36: 980-985, 1996 (in Japanese).
3. Hoftberger R, Garzyly F, Duenes HP, et al. Fulminant central nervous system demyelination associated with interferon-α therapy and hepatitis C virus infection. Multiple Sclerosis 13: 1100-1106, 2007.
4. Cornblath DR, Albers JW, Feasby TE, et al. Report from Ad Hoc Subcomittiee of the American Academy of Neurology AIDS Task Force. Research criteria for the diagnosis of chronic inflammatory demyelinating polyneuropathy. Neurology 41: 617-618, 1991.
5. Marzo E, Tintore M, Fabregues O, Montalban X, Codina A. Chronic inflammatory demyelinating polyneuropathy during treatment with interferon-α. J Neurol Neurosurg Psychiatry 65: 604, 1998.
6. Meriggioli MN, Rowin J. Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-α. Muscle Nerve 23: 433-435, 2000.
7. Caporale CM, Capasso M, Rango M, Muzio AD, Uncini A. Lewis-sumner syndrome in hepatitis C virus infection: a possible pathogenic association with therapeutic problems. Muscle Nerve 34: 116-121, 2006.
8. Couto M, Conceicao I, Carvalho MD. Steroid-responsive demyelinating motor neuropathy with conduction block associated with hepatitis C infection and treatment with interferon alpha. J Perhipher Nerv Syst 11: 353-354, 2006.
9. Luft T, Pang KC, Thomas E, et al. Type I IFNs enhance expression of the terminal differentiation of dendritic cells. J Immunol 161: 1947-1953, 1998.
10. Nissen MH, Larsen JK, Plesner T, Olesen BK, Ernst P. Alpha-interferon induces enhanced expression of HLA-ABC antigens and beta-2-microglobulin in vivo and in vitro in various subsets of human lymphoid cells. Clin Exp Immunol 69: 632-638, 1987.
11. Babchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune disease. Immunity 25: 383-392, 2006.
12. Salomon B, Rhee I, Bour-Jordan H, et al. Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. J Exp Med 194: 677-684, 2001.
13. Press R, Nennesmo I, Kouwenhoven M, Huang YM, Link H, Pashenkov M. Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradicuoneuropathy. J Neuroimmunol 159: 165-176, 2005.
14. Koskinas J, Kilidireas C, Karandreas N, et al. Severe hepatitis C virus-related cryoglobulinemic sensory-motor polyneuropathy treated with pegylated interferon-a2b and ribavirin: clinical, laboratory and neurophysiological study. Liver Int 27: 414-420, 2007.
15. Costa J, Resende C, Carvalho M. Motor-axonal polyneuropathy associated with hepatitis X virus. Eur J Neurol 10: 183-185, 2003.
16. Caniatti LM, Tugnoli V, Eleopa R, et al. Cryoglobulinemic neuropathy related to hepatitis C virus infection. Clinical, laboratory and neurophysiological study. J Peripher Nerv Syst 1: 131-138, 1996.
17. Klein C, Logigian E, Suarez G. Neurological manifestations of systemic diseases: cryoglobulinemia. In: Neurological Therapeutics. vol. II. Noseworthy J, Ed. Dunitz, Martin, 2003: 1272-1282.
18. Boukhris S, Magy L, Senga-mokono U, et al. Polyneuropathy with demyelinating features in mixed cryoglobulinemia with hepatitis C virus infection. Eur J Neurol 13: 937-941, 2006.